Skip to main content
Erschienen in: International Journal of Hematology 6/2017

07.03.2017 | Original Article

Predictors of vasovagal reactions during preoperative autologous blood donation: a single-institution analysis

verfasst von: Hisakazu Nishimori, Nobuharu Fujii, Keiko Fujii, Tohru Ikeda, Naomi Asano, Hiroaki Ogo, Miwa Yamakawa, Naoe Takagi, Fumio Otsuka, Kazuma Ikeda

Erschienen in: International Journal of Hematology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Studies examining risk factors associated with vasovagal reactions (VVRs) during autologous blood donations, especially in younger subjects, have been limited. The aim of the present study was to define risk factors for VVRs during preoperative autologous blood donation in patients, including those younger than 18 years old. We retrospectively analyzed 4192 autologous, preoperative blood donations between 2007 and 2015 at Okayama University Hospital. Eighty-seven (2.08%) of the patients experienced VVRs. VVRs occurred approximately three times as often in patients 0–17 years old (16/320, 5.0%) than in patients 18 years and older (71/3872, 1.8%). In particular, VVRs occurred more frequently in those 10–13 years old, and decreased with older age (P = 0.006). In a univariate analysis, younger age, lower body mass index, lower systolic blood pressure, lower body weight, lower total blood volume, female gender, first-time collection, and higher heart rate were associated with a higher incidence of VVRs. In a multivariate analysis, lower systolic blood pressure (P < 0.001), higher heart rate (P = 0.007), and first-time collection (P = 0.015), remained independent predictors of VVRs. These results emphasize the need for careful attention during blood collection.
Literatur
1.
Zurück zum Zitat Gandini G, Franchini M, de Gironcoli M, Giuffrida A, Bertuzzo D, Zanolla L, et al. Preoperative autologous blood donation by elderly patients undergoing orthopaedic surgery. Vox Sang. 2001;80:95–100.CrossRefPubMed Gandini G, Franchini M, de Gironcoli M, Giuffrida A, Bertuzzo D, Zanolla L, et al. Preoperative autologous blood donation by elderly patients undergoing orthopaedic surgery. Vox Sang. 2001;80:95–100.CrossRefPubMed
2.
Zurück zum Zitat Trouern-Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion. 1999;39:316–20.CrossRefPubMed Trouern-Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion. 1999;39:316–20.CrossRefPubMed
3.
Zurück zum Zitat Tomita T, Takayanagi M, Kiwada K, Mieda A, Takahashi C, Hata T. Vasovagal reactions in apheresis donors. Transfusion. 2002;42:1561–6.CrossRefPubMed Tomita T, Takayanagi M, Kiwada K, Mieda A, Takahashi C, Hata T. Vasovagal reactions in apheresis donors. Transfusion. 2002;42:1561–6.CrossRefPubMed
4.
Zurück zum Zitat Kasprisin DO, Glynn SH, Taylor F, Miller KA. Moderate and severe reactions in blood donors. Transfusion. 1992;32:23–6.CrossRefPubMed Kasprisin DO, Glynn SH, Taylor F, Miller KA. Moderate and severe reactions in blood donors. Transfusion. 1992;32:23–6.CrossRefPubMed
6.
Zurück zum Zitat Tomasulo PA, Anderson AJ, Paluso MB, Gutschenritter MA, Aster RH. A study of criteria for blood donor deferral. Transfusion. 1980;20:511–8.CrossRefPubMed Tomasulo PA, Anderson AJ, Paluso MB, Gutschenritter MA, Aster RH. A study of criteria for blood donor deferral. Transfusion. 1980;20:511–8.CrossRefPubMed
8.
Zurück zum Zitat Nakane T, Nakamae H, Koh H, Nakamae M, Aimoto R, Terada Y, et al. Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors. Int J Hematol. 2010;91:478–84.CrossRefPubMed Nakane T, Nakamae H, Koh H, Nakamae M, Aimoto R, Terada Y, et al. Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors. Int J Hematol. 2010;91:478–84.CrossRefPubMed
9.
Zurück zum Zitat Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224–32.PubMed Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51:224–32.PubMed
10.
Zurück zum Zitat Crocco I, Franchini M, Garozzo G, Gandini AR, Gandini G, Bonomo P, et al. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus. 2009;7:35–8.PubMedPubMedCentral Crocco I, Franchini M, Garozzo G, Gandini AR, Gandini G, Bonomo P, et al. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus. 2009;7:35–8.PubMedPubMedCentral
11.
Zurück zum Zitat McVay PA, Andrews A, Kaplan EB, Black DB, Stehling LC, Strauss RG, et al. Donation reactions among autologous donors. Transfusion. 1990;30:249–52.CrossRefPubMed McVay PA, Andrews A, Kaplan EB, Black DB, Stehling LC, Strauss RG, et al. Donation reactions among autologous donors. Transfusion. 1990;30:249–52.CrossRefPubMed
12.
Zurück zum Zitat Kasper SM, Weimbs G, Sabatowski R, Wassmer G. A randomized crossover trial of IV fluid replacement versus no fluid replacement in autologous blood donors with cardiovascular disease. Transfusion. 2002;42:226–31.CrossRefPubMed Kasper SM, Weimbs G, Sabatowski R, Wassmer G. A randomized crossover trial of IV fluid replacement versus no fluid replacement in autologous blood donors with cardiovascular disease. Transfusion. 2002;42:226–31.CrossRefPubMed
13.
Zurück zum Zitat Masuda M, Kawachi Y, Inaba S, Matsuzaki K, Fukumura F, Morita S, et al. Preoperative autologous blood donations in pediatric cardiac surgery. Ann Thorac Surg. 1995;60:1694–7.CrossRefPubMed Masuda M, Kawachi Y, Inaba S, Matsuzaki K, Fukumura F, Morita S, et al. Preoperative autologous blood donations in pediatric cardiac surgery. Ann Thorac Surg. 1995;60:1694–7.CrossRefPubMed
14.
Zurück zum Zitat Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion. 1995;35:734–7.CrossRefPubMed Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion. 1995;35:734–7.CrossRefPubMed
15.
Zurück zum Zitat AuBuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion. 1991;31:513–7.CrossRefPubMed AuBuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion. 1991;31:513–7.CrossRefPubMed
16.
Zurück zum Zitat Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA. 1989;262:1963–8.CrossRefPubMed Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA. 1989;262:1963–8.CrossRefPubMed
17.
Zurück zum Zitat Newman BH. Vasovagal reactions in high school students: findings relative to race, risk factor synergism, female sex, and non-high school participants. Transfusion. 2002;42:1557–60.CrossRefPubMed Newman BH. Vasovagal reactions in high school students: findings relative to race, risk factor synergism, female sex, and non-high school participants. Transfusion. 2002;42:1557–60.CrossRefPubMed
18.
Zurück zum Zitat Eder AF, Hillyer CD, Dy BA. Notari EPt, Benjamin RJ. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA. 2008;299:2279–86.CrossRefPubMed Eder AF, Hillyer CD, Dy BA. Notari EPt, Benjamin RJ. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA. 2008;299:2279–86.CrossRefPubMed
19.
Zurück zum Zitat Laitinen T, Hartikainen J, Vanninen E, Niskanen L, Geelen G, Lansimies E. Age and gender dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol. 1998;84:576–83.PubMed Laitinen T, Hartikainen J, Vanninen E, Niskanen L, Geelen G, Lansimies E. Age and gender dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol. 1998;84:576–83.PubMed
20.
Zurück zum Zitat Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971;29:424–31.CrossRefPubMed Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971;29:424–31.CrossRefPubMed
21.
Zurück zum Zitat Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71.CrossRefPubMedPubMedCentral Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Steptoe A, Sawada Y. Assessment of baroreceptor reflex function during mental stress and relaxation. Psychophysiology. 1989;26:140–7.CrossRefPubMed Steptoe A, Sawada Y. Assessment of baroreceptor reflex function during mental stress and relaxation. Psychophysiology. 1989;26:140–7.CrossRefPubMed
23.
Zurück zum Zitat Ogata H, Iinuma N, Nagashima K, Akabane T. Vasovagal reactions in blood donors. Transfusion. 1980;20:679–83.CrossRefPubMed Ogata H, Iinuma N, Nagashima K, Akabane T. Vasovagal reactions in blood donors. Transfusion. 1980;20:679–83.CrossRefPubMed
24.
Zurück zum Zitat Takanashi M, Odajima T, Aota S, Sudoh M, Yamaga Y, Ono Y, et al. Risk factor analysis of vasovagal reaction from blood donation. Transfus Apher Sci. 2012;47:319–25.CrossRefPubMed Takanashi M, Odajima T, Aota S, Sudoh M, Yamaga Y, Ono Y, et al. Risk factor analysis of vasovagal reaction from blood donation. Transfus Apher Sci. 2012;47:319–25.CrossRefPubMed
26.
Zurück zum Zitat Eder AF, Dy BA, Kennedy JM, Notari Iv EP, Strupp A, Wissel ME, et al. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion. 2008;48:1809–19.CrossRefPubMed Eder AF, Dy BA, Kennedy JM, Notari Iv EP, Strupp A, Wissel ME, et al. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion. 2008;48:1809–19.CrossRefPubMed
27.
Zurück zum Zitat Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B. Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion. 2008;48:1799–808.CrossRefPubMed Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B. Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion. 2008;48:1799–808.CrossRefPubMed
Metadaten
Titel
Predictors of vasovagal reactions during preoperative autologous blood donation: a single-institution analysis
verfasst von
Hisakazu Nishimori
Nobuharu Fujii
Keiko Fujii
Tohru Ikeda
Naomi Asano
Hiroaki Ogo
Miwa Yamakawa
Naoe Takagi
Fumio Otsuka
Kazuma Ikeda
Publikationsdatum
07.03.2017
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 6/2017
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2204-6

Weitere Artikel der Ausgabe 6/2017

International Journal of Hematology 6/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.